Recce Pharmaceuticals Ltd
OTC:RECEF
Recce Pharmaceuticals Ltd
OTC:RECEF
Price:
0.22
USD
Market Closed
Market Cap:
$44.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Recce Pharmaceuticals Ltd
OTC:RECEF
|
AU |
|
F
|
First National Corp
NASDAQ:FXNC
|
US |
|
HonPrecision Inc
TWSE:7769
|
TW |
|
R
|
rYojbaba Co Ltd
NASDAQ:RYOJ
|
JP |
|
I
|
International Flavors & Fragrances Inc
F:IFF
|
US |
|
G
|
Graham Holdings Co
F:WPOB
|
US |
|
Fenix Resources Ltd
F:4ER
|
AU |
|
A
|
Allgeier SE
XMUN:AEIN
|
DE |
|
Propel Holdings Inc
F:8KO
|
CA |
|
W
|
Western Forest Products Inc
DUS:NWF
|
CA |
|
Intercede Group PLC
OTC:IRCDF
|
UK |
|
Clinuvel Pharmaceuticals Ltd
F:UR9A
|
AU |
|
V
|
Volvo AB
XMUN:VOL1
|
SE |
|
S
|
Storebrand ASA
DUS:SKT
|
NO |
|
DSM-Firmenich AG
SIX:DSFIR
|
CH |
|
Straumann Holding AG
SIX:STMN
|
CH |
|
Perma-Pipe International Holdings Inc
NASDAQ:PPIH
|
US |
|
B
|
Bank of Georgia Group PLC
OTC:BDGSF
|
UK |
|
Capital & Counties Properties PLC
LSE:CAPC
|
UK |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RECEF's stock price target?
Not Available
RECEF does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Recce Pharmaceuticals Ltd?
Projected CAGR
18%
18%
The compound annual growth rate for Revenue over the next 3 years is 18%.
